These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1746534)

  • 61. [Treatment of acute leukemias in the infancy with cytosine arabinoside].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL
    Minerva Pediatr; 1971 Jun; 23(26):1125-9. PubMed ID: 5286310
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.
    Evans DI; Jones PH; Morley CJ
    Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated.
    Chaoui D; Peffault De Latour R; Legrand O; Marie JP
    Leuk Lymphoma; 2005 Mar; 46(3):401-4. PubMed ID: 15621830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
    Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 66. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
    Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
    Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 69. Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.
    Leone G; Pagano L; Marra R; Di Pietro N; Storti S; Sica S; D'Onofrio G; Ganzina F
    Haematologica; 1989; 74(1):57-61. PubMed ID: 2498185
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside.
    Letendre L; Niedringhaus RD; Therneau TM; Gastineau DA; Goldberg RM; Gerstner JB; Mailliard JA; Gundlach WJ; Kardinal CG; Pierre RV
    Med Pediatr Oncol; 1989; 17(2):79-82. PubMed ID: 2704340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of the response of patients with acute nonlymphocytic leukemia to cytosine arabinoside (NSC-63878) therapy.
    Burns CP; Armentrout SA; Stjernholm RL
    Cancer Chemother Rep; 1972 Aug; 56(4):527-34. PubMed ID: 4507687
    [No Abstract]   [Full Text] [Related]  

  • 73. Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients.
    Hartmann F; Jacobs G; Gotto H; Schwamborn J; Pfreundschuh M
    Leuk Lymphoma; 2001 Jul; 42(3):347-55. PubMed ID: 11699399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide.
    Shepherd JD; Reece DE; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Phillips GL
    Leuk Lymphoma; 1993 Feb; 9(3):211-5. PubMed ID: 8471979
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Results of induction therapy in newly diagnosed acute myeloid leukemias in study 911 at the Institute of Hematology and Blood Transfusion].
    Lemez P; Vítek A; Jelínek J; Lukásová M; Palecek A; Sajdová J; Jedlicková A; Vorlová Z
    Vnitr Lek; 1995 Jan; 41(1):34-9. PubMed ID: 7716891
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
    Cassileth PA; Lee SJ; Litzow MR; Miller KB; Stadtmauer EA; Tallman MS; Lazarus HM; Bennett JM; Paietta E; Dewald GW; Rowe JM;
    Leuk Lymphoma; 2005 Jan; 46(1):55-61. PubMed ID: 15621781
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 79. Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: a Southwest Oncology Group Study.
    Steuber CP; Humphrey GB; McMillan CW; Vietti TJ
    Med Pediatr Oncol; 1978; 4(4):337-42. PubMed ID: 281596
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved prognosis of acute nonlymphocytic leukemia in children: results of the 12th-ANLL protocol of Tokyo Children's Cancer Study Group.
    Bessho F; Kigasawa H; Tsuchida M; Tsukimoto I; Nakazawa S; Yamamoto M; Tsunematsu Y; Yamada K; Sugita K; Ohkawa Y
    Acta Paediatr Jpn; 1991 Aug; 33(4):533-9. PubMed ID: 1792913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.